Article Text

Download PDFPDF
The role of baroreflex activation therapy in sympathetic modulation for the treatment of resistant hypertension

Statistics from


  • Competing interests Dr. Bisognano has received research grants and honoraria from CVRx, the manufacturer of the Rheos and Neo systems and serves as a consultant and member of scientific advisory boards for CVRx. Minimal assistance with diagrams was obtained from CVRx.

  • Ethics approval The clinical trials summarised in this editorial were all approved by the appropriate local institutional review boards and, if necessary, ethics boards.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.